Member Info for Pingu777

28th January

So let us get this straight. You're suggesting HEMO might not even get through the trials as they wont have enough cash?

There's a contrarian view and there's complete make believe.

You remind me of Stu. A lot. Banging the drum of doom and gloom is tricky though when you know longer get those Peterhouse leaks bro ;-)

The thing we all know very well though is that it all takes time.

Im intrigued to see how the traders and shorters play this though over the coming months. Trying to sell and buy a bit cheaper has worked for many, many times in the last few years. Im not so sure attempting this is a great idea any more where we're at.

A £14m Mcap really does mess with your mind. I remain fully convinced we're getting there and it will all be working itself out soon enough in terms of the SP.

i thought the mcap would be a long way north. i'd say all junior pharma is pretty shot currently. investor risk appetites seems low and so does holding for an actual long term (7yrs+). the english markets in particular are dead. if we were in america we would be worth substantially more imo.

i see car t getting bought this year. some sort of partnership (upfront cash, £30m say, and maybe 15% royalties on commercialisation, something like that). car t is inextricably linked to cdx in its design and make-up and a successful car t will go a long way to validating cdx bringing fully in to focus of big pharma also. it wouldnt surprise me if on the success of car t any buyer wants cdx with it also.

and then we're funded for the game-changer... cbr. this is where my valuation of the above moves from the singular to the plural in terms of £billion(s). obviously its much earlier in its development but the success of car t gives very strong indications that hemo are **** hot and cbr may very well do what it says on the tin.

it would be very nice to hear of big pharma sniffing around by q4 this year. but i suspect our sp will be heading north much sooner on the positive indications with the first few patients. in fact, as i've said, i think it begins once this placing funding is secured.

It seemed so in your post. Fair enough.

Then you know why you are here? Did you think they'd spend magic money and not place? They're not profit making. Placings are inevitable. Its the business model.

It also mean HEMO has retained 100% ownership of the drug which would have been forfeited with any other equity-share financing structure.

You cant have your cake and eat it.

Unnecessary all at once. Wont happen.

Id rather we were £15 now ConsDoms but it rather means little sadly.

The small minds of AIM can't comprehend the actual end game for a high quality junior pharma. HEMOs IP is beyond comprehension for most. Vlad has told everyone. But short-sightedness rules most minds.

You have AIM thinking. Pharma investing targets huge multiples. You do understand this concept? I'll use Vlads quote 'billions and years'.

25% dilution at £14m mcap means very little if the drugs are worth £1b+. Does this make sense?

You are disappointing Pumper. On so many levels. Beyond belief.

What if they place at £4 and then hit £50 in 2025?

Your shortsightedness and lack of intelligence is meticulously draining. If an Alien came to earth, and didn't understand any earth-talk whatsoever, and then learnt a language that had a word for draining, and then they didn't quite understand its meaning, I'd direct them to your chat history for a very very very detailed explanation.

Draining: see Pumpky.

Anyone thinking there’s some sort of trading window here really does need to be careful. We’re closing in on zero hour. Go time.

This is the beginning of a new era, a new age. How much is a working CAR T treatment worth that replaces chemo again?

A small sample of patient data only needed to satisfy Big Pharma…

Funding imminent. Don’t wanna be out of this over the weekend that’s for sure. The frequency of brilliant RNSs from HEMO of late has been incredibly impressive…. Vlad getting his aft together at the right time.

When the funding RNS lands HEMO approach the launchpad. Imminent BOOM time. It’s the only thing holding investors back right now as many expect a big discount and dip. I don’t.

I expect a good deal for HEMO and all investors.

Oh Geez, one last time…

Kymriah does not treat AML. It’s for ALL.

Have a good Boxing Day people.

*Kymriah

Dam autocorrect.

Ky rush treat ALL not AML.

100% agree.

There is no CAR T out there now that cures any cancer without taking chemo. HEMO CAR T aims to do break that mould.

Im not sure people really get it here.

Just read it take 10-15 years to get a drug from target to launch. HEMO has cleared pre clinical and got CAR T into trial in 3 years?

Tom Winnifreth can suck my chimichangas.

Peace out, good luck all.

Forget everything else.

How much is HEMO CAR T worth if it works?

Merry Christmas all (apart from Pumpky).

Sounds about right for the process.

However, who says it hasn't started yet?

Mickey

Raises do damage when we go to Peterhouse. Its proven. Existing holders sell their stock down and then buy the placing. The ones who sort it get double bubble.

However, what if a raise is done with a reputable establishment? And they dont sell. But hold.

Then what? All speculation of course. But this is the direction HEMO is heading. A fully funded HEMO will see the dullards disappear as if by magic.